MYH9 and prostate carcinoma: Our results indicate that MYH9 overexpression effectively suppresses prostate cancer through interactions with cell adhesion molecules.<h4>Conclusion</h4>Collectively, these results suggest that OTUD4 functions as a tumor suppressor in prostate cancer.